510(k) device
Foundation Dermal Regeneration Scaffold (DRS) Solo
Bionova Medical, Inc. · Wound Dressing With Animal-Derived Material(S) (KGN, Unclassified) · First FDA decision Aug 11, 2022, newest Nov 13, 2023BurnsChronic wounds and ulcers
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
2
510(k) pathway
Device trials
0
Naming "Foundation Dermal Regeneration"
MAUDE reports
0
Brand "Foundation Dermal Regeneration", since 2015
PubMed studies
0
Mentioning "Foundation Dermal Regeneration"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Foundation Dermal Regeneration Scaffold (DRS) Solo
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 2 of 2 decisions filed under this name.
K231937 · Decided Nov 13, 2023 · 136 days after receipt
Device type: Wound Dressing With Animal-Derived Material(S) (KGN) · General & Plastic Surgery
K210949 · Decided Aug 11, 2022 · 499 days after receipt
Device type: Wound Dressing With Animal-Derived Material(S) (KGN) · General & Plastic Surgery
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Foundation Dermal Regeneration", any status and sponsor, newest update first.
No registered device study names "Foundation Dermal Regeneration".
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Foundation Dermal Regeneration", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code KGN
154 reports: 32 malfunction, 117 injury, 1 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Foundation Dermal Regeneration"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code KGN.
- Cytal® Wound MatrixAcell, Inc. · 510(k) 2024
- PriMatrix Dermal Repair ScaffoldTei Biosciences, Inc. · 510(k) 2016
- Marigen Wound ExtraKerecis Limited · 510(k) 2025
- MatriDermMedskin Solutions Dr. Suwelack AG · 510(k) 2026
- CollOvine Wound PowderOvigenex, LLC · 510(k) 2026
- SurgiAid Collagen Wound Dressing (HA)Maxigen Biotech, Inc. · 510(k) 2025
- Collagen Wound DressingWinner Medical Co., Ltd. · 510(k) 2025
- Corplex P/ Theracor P/ Allacor PStimlabs, LLC · 510(k) 2024
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.